1310P Loratadine: A potential game-changer in lung cancer treatment with improved survival outcomes
Xianjing Liu(Erasmus MC), Jianxing He(First Affiliated Hospital of Guangzhou Medical University), Jun Huang(Guangdong Pharmaceutical University), Wenhua Liang(First Affiliated Hospital of Guangzhou Medical University), Ran Zhong(First Affiliated Hospital of Guangzhou Medical University), Rui Zeng(First Affiliated Hospital of Guangzhou Medical University), Hongxia Deng(Ningbo University), Ming-Ming He(Sun Yat-sen University), Jing Li(First Affiliated Hospital of Guangzhou Medical University), Liteng Lin(Second Affiliated Hospital of Guangzhou Medical University), Zhen Chen(Taixing People's Hospital), Cancan Li(Guangzhou Medical University), Yong Zheng(First Affiliated Hospital of Guangzhou Medical University), Qiuyin Cai(Vanderbilt University), S. Lao(First Affiliated Hospital of Guangzhou Medical University), Huifang Xu(Guangdong Provincial Hospital of Traditional Chinese Medicine)
Cited by 0
Related Papers
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
|PLoS ONE|2018|1.2k
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
|Nature Genetics|2014|1.1k
Meta-analysis identifies common variants associated with body mass index in east Asians
|Nature Genetics|2012|405